blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1218570

EP1218570 - RADIOACTIVELY COATED DEVICE AND METHOD OF MAKING SAME FOR PREVENTING RESTENOSIS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.12.2004
Database last updated on 15.06.2024
Most recent event   Tooltip23.10.2009Change - representativepublished on 25.11.2009  [2009/48]
Applicant(s)For all designated states
Angiogene, Inc.
Suite Y-1605, 1560 rue Sherbrooke Est
Montréal, Québec H2L 4M1 / CA
[2002/27]
Inventor(s)01 / Leclerc, Guy
327, rue Lorraine
Rosemère, Québec J7A 4K1 / CA
02 / Fareh, Jeannette
5150, rue Garnier
Montréal, Québec H2J 3T2 / CA
03 / Leblanc, Philippe
155, rue Grenier
St-Luc, Québec J2N 1Y8 / CA
04 / Levesque, Luc
141, rue Benjamin-Sulte
Boucherville, Québec J4B 2L8 / CA
05 / Martel, Rémi
4865, rue La Fontaine
Montréal, Québec H1V 1R5 / CA
06 / Kudrevich, Svetlana
55, chemin de la Côte Ste-Catherine, Apt. 1804
Montréal, Québec H2A 2A5 / CA
07 / Lawrence, Marcus F.
1479 Rue Noel-Lareau
Chambly, Quebec J3L 5ML / CA
08 / Bourguignon, Bernard
4738 Rue des Erables
Montréal, Quebec H2H 2C9 / CA
09 / Lessard, Jean
1585 Longchamp
Sherbrooke, Quebec J1J 1H9 / CA
10 / Blais, Sonia
19 Wilkinson Way
Princeton, NJ 08540 / US
11 / Chapuzet, Jean-Marc
4070 Rouleau
Sherbrooke, Quebec J1K 2R1 / CA
12 / Meunier, Michel
4949 Félix McLernan
Pierrefonds, Québec H8y 3l2 / CA
13 / Napporn, Têko
5045 Clanranald, No 305
Montréal, Quebec H3X 2S3 / CA
14 / Poulin, Suzie
5775 Paul-Pau
Montréal, Quebec H1K 2N2 / CA
15 / Sacher, Edward
5739 Kincourt Avenue
Côte St.-Luc, Québec H4W 1Y7 / CA
16 / Savadogo, Oumarou
12125 Lavigne
Montréal, Québec H4J 1Y1 / CA
 [2002/27]
Representative(s)Ouzman, Beverley Nicola Claire, et al
Murgitroyd & Company
Scotland House
165-169 Scotland Street
Glasgow G5 8PL / GB
[N/P]
Former [2009/48]Ouzman, Beverley Nicola Claire, et al
Murgitroyd & Company Scotland House 165-169 Scotland Street
Glasgow G5 8PL / GB
Former [2002/27]Ouzman, Beverley Nicola Claire, et al
Murgitroyd and Company, 165-169 Scotland Street
Glasgow G5 8PL / GB
Application number, filing date00955988.122.08.2000
[2002/27]
WO2000CA00974
Priority number, dateUS19990149897P23.08.1999         Original published format: US 149897 P
[2002/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0114617
Date:01.03.2001
Language:EN
[2001/09]
Type: A1 Application with search report 
No.:EP1218570
Date:03.07.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 01.03.2001 takes the place of the publication of the European patent application.
[2002/27]
Search report(s)International search report - published on:EP01.03.2001
ClassificationIPC:C25D13/04, C09D5/44, C25D9/00, A61F2/06, A61M29/02, A61L31/08
[2002/27]
CPC:
A61F2/82 (EP); A61L31/082 (EP); C09D5/44 (EP);
C25D13/04 (EP); A61F2210/0095 (EP); A61M25/0045 (EP);
A61M25/104 (EP); A61N5/1002 (EP) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/27]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:RADIOAKTIV BESCHICHTETES GERÄT UND METHODE ZUR VORBEUGUNG VON RESTENOSE[2002/27]
English:RADIOACTIVELY COATED DEVICE AND METHOD OF MAKING SAME FOR PREVENTING RESTENOSIS[2002/27]
French:DISPOSITIF A REVETEMENT RADIOACTIF ET PROCEDE DE FABRICATION DE CE DERNIER DESTINE A EMPECHER LA RESTENOSE[2002/27]
Entry into regional phase26.02.2002National basic fee paid 
26.02.2002Designation fee(s) paid 
26.02.2002Examination fee paid 
Examination procedure22.03.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.02.2002Examination requested  [2002/27]
04.11.2002Despatch of a communication from the examining division (Time limit: M06)
08.05.2003Reply to a communication from the examining division
10.06.2003Despatch of a communication from the examining division (Time limit: M06)
08.12.2003Reply to a communication from the examining division
23.02.2004Despatch of a communication from the examining division (Time limit: M01)
01.03.2004Reply to a communication from the examining division
23.03.2004Communication of intention to grant the patent
03.08.2004Application deemed to be withdrawn, date of legal effect  [2005/06]
08.09.2004Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2005/06]
Fees paidRenewal fee
14.08.2002Renewal fee patent year 03
13.08.2003Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.08.200405   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]DE19724223  (SCHERING AG [DE]) [X] 1,4-7,9-11,14-16,19-23,31-39,46 * claims 1-5 *;
 [X]WO9902195  (IMPLANT SCIENCES CORP [US], et al) [X] 1,4-7,9-11,14-16,19,23,29,31-33,36-39,46 * claims 20,23,26,27 *;
 [X]WO9817331  (COOK INC [US], et al) [X] 1,2,24,25,30,33,37,40,41,45,46 * claims 1,12,41-47 *;
 [X]EP0819446  (ADVANCED CARDIOVASCULAR SYSTEM [US]) [X] 1,3,8,24,30,40,45 * claims 1,5,7 *;
 [A]WO9823299  (ANGIOGENE CANADA INC [CA], et al) [A] 1,24,25 * claims 1,2,14 *;
 [A]WO9311120  (ZYNAXIS TECHNOLOGIES INC [US]) [A] 1,3,18 * claims 1,19,28,30,96 *;
 [A]EP0857470  (SORIN BIOMEDICA CARDIO SPA [IT]) [A] 1 * claims 1,10 *;
 [A]EP0824902  (KANESAKA NOZOMU [US], et al) [A] 1 * claims 1,10,12 * * column 5, line 54 - column 6, line 2 *;
 [PX]US6077413  (HAFELI URS [US], et al) [PX] 1,2,4,5,9-17,19-23,29,31-39,46 * claims 1-10,12 * * example - *;
 [PX]WO0029501  (UNIV EMORY [US], et al) [PX] 1 * claim 1 *;
 [PX]DE19819426  (HEHRLEIN CHRISTOPH [DE]) [PX] 1,22,23 * claims 1,2,14,16 *;
 [PX]WO0010615  (HERBST FRANZ [DE], et al) [PX] 1,22,23 * claims 1,2,103,104 *;
 [PX]US5980566  (ALT ECKHARD [DE], et al) [PX] 1,16 * claims 1,21 * * column 6, line 56 - column 7, line 8 *
 [DX]  - HAFELI U O ET AL, "Electrodeposition of radioactive rhenium onto stents to prevent restenosis", BIOMATERIALS,GB,ELSEVIER SCIENCE PUBLISHERS BV., BARKING, (19980501), vol. 19, no. 10, ISSN 0142-9612, pages 925 - 933, XP004124453 [DX] 1,2,4-7,9-23,29,31-39,46,48 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0142-9612(98)00003-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.